Picture: Peter Shanks.

COVID-19 vaccine technology benefits devils

Since the emergence of the facial fungal disease during the mid-1990s that has decimated Tasmanian devil populations in the wild, scientists have been working on developing a vaccine that can protect the species and slow the spread of the fatal cancer. Although there was limited success with an earlier immunotherapy trial, that saw some captive-bred […]

Continue Reading

Signs shown of genetic resistance to DFTD

Research by an international team of scientists, published at the end of August in the journal Nature Communications, shows two regions in the genomes of Tasmanian devils (Sarcophilus harrisii) appear to be evolving in response to the fatal facial tumour disease that has ravaged populations in the wild for almost 20 years. Evolutionary geneticist Andrew […]

Continue Reading